Refine by
Cancer Specific Biomarker Equipment & Supplies
6 equipment items found
Manufactured by:OncoDNA S.A. based inGosselies, BELGIUM
OncoSELECT: Smart liquid biopsy panels with selected key genes per tumor type. The Liquid Biopsy Solution For Disease Monitoring Or Therapeutic Decision. OncoSELECT is a fast and minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colorectal and breast (HR+ or HER2+) cancer patients. It is the perfect solution to identify therapeutic options for cancer ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer-specific biomarkers in patient urine sample or biopsy tissue sample to distinguish prostate cancer from benign patients or normal ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
What is early diagnosis? Early diagnosis helps people to plan ahead while they are still able to make important decisions on their care and support needs and on financial and legal ...
Manufactured by:OncoDNA S.A. based inGosselies, BELGIUM
Oncodeep® is a comprehensive biomarker test designed to guide treatment of advanced, metastatic solid tumors. When your patients are diagnosed with a rare cancer type or an aggressive cancer, when chemotherapy doesn't work or when cancer comes back, OncoDEEP® can provide you with clear clinical guidance. Starting from a small sample of tumor tissue, our biomarker test is able to pinpoint ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer risk-associated biomarkers in patient urine sample or biopsy tissue sample to distinguish high-risk and aggressive prostate cancer needing immediate treatment from low-risk and indolent prostate cancer needing only ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A prognostic test kit quantitatively measures the expression levels of a panel of metastasis-specific biomarkers in patient urine sample or biopsy tissue sample to detect existing metastatic prostate cancer and predict prostate cancer that will become metastatic in the ...